NDC 0574-0201

VIGABATRIN

Vigabatrin

VIGABATRIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Padagis Us Llc. The primary component is Vigabatrin.

Product ID0574-0201_05bc949b-e493-4379-a134-a000d134cf22
NDC0574-0201
Product TypeHuman Prescription Drug
Proprietary NameVIGABATRIN
Generic NameVigabatrin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-06-29
Marketing CategoryANDA /
Application NumberANDA215109
Labeler NamePadagis US LLC
Substance NameVIGABATRIN
Active Ingredient Strength500 mg/1
Pharm ClassesAnti-epileptic Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0574-0201-01

100 TABLET in 1 BOTTLE (0574-0201-01)
Marketing Start Date2022-06-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "VIGABATRIN" or generic name "Vigabatrin"

NDCBrand NameGeneric Name
0054-0652VigabatrinVigabatrin
0574-0201VIGABATRINvigabatrin
0574-0470VIGABATRINvigabatrin
0591-3851VigabatrinVigabatrin
0591-3955vigabatrinvigabatrin
16729-521VigabatrinVigabatrin
42799-950VigabatrinVigabatrin
43598-651VigabatrinVigabatrin
43598-697VigabatrinVigabatrin
49884-358VIGABATRINvigabatrin
59651-366VigabatrinVigabatrin
59651-367VigabatrinVigabatrin
64850-940Vigabatrinvigabatrin
69238-1425VigabatrinVigabatrin
69097-964VIGABATRINVIGABATRIN
67877-674VIGABATRINVIGABATRIN
67386-111SABRILvigabatrin
67386-211SABRILvigabatrin
31722-009vigabatrin for oral solutionvigabatrin
0054-0702Vigabatrin for oral solution USP, 500 mgVigabatrin
0245-0556VIGADRONEvigabatrin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.